Meghana Keshavan from STAT News - Journalist Profile

	Profile	Recent Articles on Subject
1	Meghana Keshavan STAT News Biotech nerd and writer @statnews. biotechwriting	The view from overseas on tumult in U.S. science - 9 days ago The biotech news stories you need to read today - 10 days ago The biotech news stories we’re keeping an eye on - about 1 month ago Eli Lilly seeks to join lawsuit on compounded drugs - about 2 months ago Merck is a new year outlier with its diabetes drug - about 2 months ago STAT+: Vertex drug for cystic fibrosis wins approval - 2 months ago GLP-1 drugs spark disagreements in Trump’s circle - 2 months ago Biopharma leaders lay out vision for the future of blood cancer treatment - 3 months ago STAT+: Pfizer’s abrupt withdrawal of sickle cell drug Oxbryta called ‘tone deaf’ at ASH conference - 3 months ago Sanofi pours $1 billion into China for insulin plant - 3 months ago Despite probe, China reimbursing AstraZeneca drug - 3 months ago The biotech news you need to read today - 3 months ago More beef in the gene editing space - 3 months ago Versant enters obesity with new startup - 3 months ago A win for Apellis, a setback for Astellas - 3 months ago Risk of aspiration during surgery added to GLP-1 drug labels - 3 months ago The biotech news roundup to start your week - 4 months ago A setback for the tau approach to Alzheimer’s - 4 months ago The biotech news you need to read today - 4 months ago STAT+: Potential competition for RSV prophylactic Beyfortus - 4 months ago Eli Lilly releases new data on weekly insulin - 5 months ago Lilly has more positive data on its weekly insulin - 6 months ago STAT+: Rick Doblin, ‘unleashed,’ blasts FDA over Lykos drug rejection and turns to global push for MDMA therapy - 6 months ago Is pharma still fearful of the Inflation Reduction Act? - 6 months ago STAT+: Lykos Therapeutics cuts 75% of staff after FDA rejects MDMA-assisted therapy - 6 months ago A tough week for MDMA-assisted psychotherapy - 6 months ago STAT+: Three MDMA therapy papers retracted over data integrity concerns - 7 months ago FDA rejects MDMA as a psychedelic treatment for PTSD - 7 months ago STAT+: Why did Novo pull heart failure paperwork for Wegovy? - 7 months ago Element Biosciences raises another massive round - 8 months ago The biotech news you missed this week - 8 months ago Will Medicare finally begin covering weight loss drugs like Zepbound and Wegovy? - 8 months ago STAT+: More tumult at BIO amid the company’s fourth CEO in four years - 9 months ago ICER casts doubt on Sarepta’s DMD gene therapy - 10 months ago The latest updates on cancer research from the weekend - 11 months ago Sanofi resolves most Zantac litigation - 11 months ago How resurrecting extinct species might impact medicine - 11 months ago New data on liquid biopsy for colorectal cancer detection still underwhelms - 11 months ago Lawmakers want to add more Chinese biotechs to defense list - 11 months ago How GLP-1’s moved from research labs to national TV - 11 months ago How will the Supreme Court’s mifepristone decision impact biopharma? - 11 months ago EU adviser says Illumina merger was not problematic - 11 months ago What happens when an approved drug doesn’t work? - 11 months ago Eli Lilly’s anti-vanity ad campaign for Oscars - 12 months ago Serum Institute of India wants government HPV contract - 12 months ago Despite good data, Ironwood’s shares plummet - 12 months ago What do CEOs owe the world? - 12 months ago Replicate’s srRNA rabies vaccine effective in Phase 1 - about 1 year ago The need to know biotech news stories today - about 1 year ago Psychedelic investment continues to ramp up - about 1 year ago
2	Angus Chen STAT News Undignified, unfunny journalist. Health, cancer coverage at STAT News. journalismhealthcancer researchSTAT News	Biopharma leaders lay out vision for the future of blood cancer treatment - 3 months ago
3	Jonathan Wosen STAT News West Coast Biotech Reporter. Formerly @sdut. Stanford PhD. UCSC alum. San Diego, California BiotechLife SciencesImmunology	Biopharma leaders lay out vision for the future of blood cancer treatment - 3 months ago
4	Adam Feuerstein STAT News Reporter at STATnews. Dog lover. Polk Award winner. Boston, Massachusetts biotech reporting	Biopharma leaders lay out vision for the future of blood cancer treatment - 3 months ago
5	Olivia Goldhill STAT News	FDA rejects MDMA as a psychedelic treatment for PTSD - 7 months ago